Maria Dall'Era, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-476-0783
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine
    University of California, San FranciscoM.D.1997School of Medicine

    Collapse Overview 
    Collapse Overview
    Maria Dall’Era, M.D. is professor of medicine in the Division of Rheumatology. Within rheumatology, her subspecialty is systemic lupus erythematosus (SLE) and lupus nephritis. Dr. Dall’Era is the director of the UCSF Lupus Clinic in which she cares for > 200 patients with SLE. She is also the director of the Rheumatology Clinical Research Center in which she oversees the conduct of various clinical trials and observational research studies. Her research program is focused on three major areas: (1) the design and conduct of clinical trials of novel biologic agents for SLE and lupus nephritis, (2) a population-based SLE longitudinal cohort funded by the Centers of Disease Control and (3) a project in conjunction with the Lupus Nephritis Trials Network to determine the most appropriate renal outcome measures that should be utilized in lupus nephritis clinical trials.
    She is the co-chair of the Steering Committee for the Lupus Clinical Investigators Network (LuCIN).

    Dr. Dall’Era plays a large role in the education of trainees, both in the outpatient clinical arena, inpatient setting, and in the medical school. With a grant from the American College of Rheumatology’s Lupus Initiative, she created two pilot, interactive, on-line, virtual simulation SLE cases in collaboration with Dr. Michelle Lin. She incorporated novel features into the cases including a “differential diagnosis slider” in which the learner is required to re-adjust their differential diagnosis after case content is revealed. With a clinician scholar award grant from the American College of Rheumatology, she developed an interactive mobile app called PIVOT to teach clinical reasoning in rheumatology.

    Dr. Dall’Era is also active in the education of practicing physicians and lectures frequently on the topic of lupus at national conferences and review courses.

    Collapse Research 
    Collapse Research Activities and Funding
    Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts - 2019
    NIH U01DP006486Sep 1, 2019 - Aug 31, 2022
    Role: Principal Investigator
    Racial/ethnic and socioeconomic disparities in biologic and clinical SLE outcomes
    NIH U01DP005120Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021 Jun; 73(6):991-996. Izmirly PM, Parton H, Wang L, McCune WJ, Lim SS, Drenkard C, Ferucci ED, Dall'Era M, Gordon C, Helmick CG, Somers EC. PMID: 33474834.
      View in: PubMed   Mentions:    Fields:    
    2. Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures. Commun Biol. 2021 Apr 21; 4(1):488. Andreoletti G, Lanata CM, Trupin L, Paranjpe I, Jain TS, Nititham J, Taylor KE, Combes AJ, Maliskova L, Ye CJ, Katz P, Dall'Era M, Yazdany J, Criswell LA, Sirota M. PMID: 33883687.
      View in: PubMed   Mentions:
    3. Impact of Limited Health Literacy on Patient-Reported Outcomes in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2021 01; 73(1):110-119. Katz P, Dall'Era M, Trupin L, Rush S, Murphy LB, Lanata C, Criswell LA, Yazdany J. PMID: 32741118.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. High Disease Severity Among Asians in a US Multiethnic Cohort of Individuals with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2020 Dec 18. DeQuattro K, Trupin L, Murphy LB, Rush S, Criswell LA, Lanata CM, Dall'Era M, Katz P, Yazdany J. PMID: 33337580.
      View in: PubMed   Mentions:    Fields:    
    5. Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results From a Prospective Longitudinal Cohort. Arthritis Care Res (Hoboken). 2021 01; 73(1):48-54. Dietz B, Katz P, Dall'Era M, Murphy LB, Lanata C, Trupin L, Criswell LA, Yazdany J. PMID: 32741124.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis. Arthritis Rheumatol. 2021 01; 73(1):121-131. Atisha-Fregoso Y, Malkiel S, Harris KM, Byron M, Ding L, Kanaparthi S, Barry WT, Gao W, Ryker K, Tosta P, Askanase AD, Boackle SA, Chatham WW, Kamen DL, Karp DR, Kirou KA, Sam Lim S, Marder B, McMahon M, Parikh SV, Pendergraft WF, Podoll AS, Saxena A, Wofsy D, Diamond B, Smilek DE, Aranow C, Dall'Era M. PMID: 32755035.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    7. Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies. Arthritis Care Res (Hoboken). 2020 Oct 07. Williams JN, Dall'Era M, Lim SS, Feldman CH, Arntsen KA, Blazer AD, Goode T, Merrill JT, Sheikh S, Stevens AM, Lipsky PE, Costenbader KH. PMID: 33026693.
      View in: PubMed   Mentions:    Fields:    
    8. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2020 07 01; 59(7):1505-1513. Aranow C, Cush J, Bolster MB, Striebich CC, Dall'era M, Mackay M, Olech E, Frech T, Box J, Keating R, Wasko MC, St Clair W, Kivitz A, Huang W, Ricketts P, Welch B, Callahan S, Spychala M, Boyle K, York K, Keyes-Elstein L, Goldmuntz E, Diamond B, Davidson A. PMID: 31628482.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    9. Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints. Kidney Int Rep. 2020 Aug; 5(8):1302-1305. Almaani S, Bhatt U, Arriens C, Bonfa E, Dall'Era M, Houssiau F, Kalunian K, Mackay M, Sanchez-Guerrero J, Solomons N, Rovin BH. PMID: 32775830.
      View in: PubMed   Mentions:
    10. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project. Arthritis Care Res (Hoboken). 2020 05; 72(5):622-629. Maningding E, Dall'Era M, Trupin L, Murphy LB, Yazdany J. PMID: 31115180.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    11. Relationships Between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2020 04; 72(4):525-533. DeQuattro K, Trupin L, Li J, Katz PP, Murphy LB, Yelin EH, Rush S, Lanata C, Criswell LA, Dall'Era M, Yazdany J. PMID: 31069933.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Nat Commun. 2020 02 27; 11(1):1164. Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Criswell LA. PMID: 32109229.
      View in: PubMed   Mentions:    Fields:    
    13. Psychometric Evaluation of the National Institutes of Health Patient-Reported Outcomes Measurement Information System in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort. Arthritis Care Res (Hoboken). 2019 12; 71(12):1630-1639. Katz P, Yazdany J, Trupin L, Rush S, Helmick CG, Murphy LB, Lanata C, Criswell LA, Dall'Era M. PMID: 30354017.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019 Oct; 20(10):1404. Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B, Accelerating Medicines Partnership in SLE network . PMID: 31409923.
      View in: PubMed   Mentions:    Fields:    
    15. A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Nat Commun. 2019 08 29; 10(1):3902. Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Criswell LA. PMID: 31467281.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    16. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019 07; 20(7):902-914. Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B, Accelerating Medicines Partnership in SLE network . PMID: 31209404.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    17. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. PLoS Med. 2019 05; 16(5):e1002800. Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J. PMID: 31067237.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes. Arthritis Rheumatol. 2019 03; 71(3):411-419. Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez-Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Solomons N, Houssiau FA, Romero-Diaz J, Mejia-Vilet J, Rovin BH. PMID: 30225865.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    19. Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 03; 71(3):431-440. Dall'Era M, Pauli ML, Remedios K, Taravati K, Sandova PM, Putnam AL, Lares A, Haemel A, Tang Q, Hellerstein M, Fitch M, McNamara J, Welch B, Bluestone JA, Wofsy D, Rosenblum MD, Autoimmunity Centers of Excellence . PMID: 30277008.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    20. Current challenges in the development of new treatments for lupus. Ann Rheum Dis. 2019 06; 78(6):729-735. Dall'Era M, Bruce IN, Gordon C, Manzi S, McCaffrey J, Lipsky PE. PMID: 30636212.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. Ann Rheum Dis. 2019 07; 78(7):1004-1006. Sciascia S, Yazdany J, Dall'Era M, Fenoglio R, Radin M, Aggarwal I, Cuadrado MJ, Schreiber K, Barreca A, Papotti M, Roccatello D. PMID: 30552172.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1502-1509. Gomez Mendez LM, Cascino MD, Garg J, Katsumoto TR, Brakeman P, Dall'Era M, Looney RJ, Rovin B, Dragone L, Brunetta P. PMID: 30089664.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    23. Lupus community panel proposals for optimising clinical trials: 2018. Lupus Sci Med. 2018; 5(1):e000258. Merrill JT, Manzi S, Aranow C, Askanase A, Bruce I, Chakravarty E, Chong B, Costenbader K, Dall'Era M, Ginzler E, Hanrahan L, Kalunian K, Merola J, Raymond S, Rovin B, Saxena A, Werth VP. PMID: 29657738.
      View in: PubMed   Mentions:
    24. The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project. Arthritis Rheumatol. 2017 10; 69(10):1996-2005. Dall'Era M, Cisternas MG, Snipes K, Herrinton LJ, Gordon C, Helmick CG. PMID: 28891237.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    25. Treatment of lupus nephritis: current paradigms and emerging strategies. Curr Opin Rheumatol. 2017 05; 29(3):241-247. Dall'Era M. PMID: 28207493.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    26. Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique. J Rheumatol. 2015 Sep; 42(9):1616-23. Singh JA, Qu H, Yazdany J, Chatham W, Dall'era M, Shewchuk RM. PMID: 26178276.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2015 Jul; 67(7):1848-57. Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, Coca A, Chatham WW, Clowse ME, Criscione-Schreiber LG, Callahan S, Goldmuntz EA, Keyes-Elstein L, Oswald M, Gregersen PK, Diamond B. PMID: 25777546.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    28. Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome. Lupus Sci Med. 2015; 2(1):e000089. Dall'Era M, Levesque V, Solomons N, Truman M, Wofsy D. PMID: 26023331.
      View in: PubMed   Mentions:
    29. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol. 2015 May; 67(5):1305-13. Dall'Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M. PMID: 25605554.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    30. A young woman with systemic lupus erythematosus and extensive mesenteric vasculitis involving small and medium vessels. Arthritis Care Res (Hoboken). 2012 Dec; 64(12):1928-33. Ashouri JF, Davis JL, Farkas A, Durack JC, Ramachandran R, Dall'Era M. PMID: 22933330.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Curr Opin Rheumatol. 2011 Sep; 23(5):454-8. Dall'Era M. PMID: 21720247.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    32. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Curr Rheumatol Rep. 2011 Aug; 13(4):308-16. Dall'era M, Chakravarty EF. PMID: 21584692.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011 Aug; 63(8):1170-7. Yazdany J, Trupin L, Gansky SA, Dall'era M, Yelin EH, Criswell LA, Katz PP. PMID: 21584946.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    34. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Arthritis Care Res (Hoboken). 2011 Mar; 63(3):351-7. Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. PMID: 21080348.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    35. B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin. Arthritis Res Ther. 2010; 12(2):R48. Dillon SR, Harder B, Lewis KB, Moore MD, Liu H, Bukowski TR, Hamacher NB, Lantry MM, Maurer M, Krejsa CM, Ellsworth JL, Pederson S, Elkon KB, Wener MH, Dall'Era M, Gross JA. PMID: 20302641.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    36. Connective tissue diseases: Belimumab for systemic lupus erythematosus: breaking through? Nat Rev Rheumatol. 2010 Mar; 6(3):124-5. Dall'Era M, Wofsy D. PMID: 20197774.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Biologic therapy for systemic lupus erythematosus. Discov Med. 2010 Jan; 9(44):20-3. Dall'Era M, Wofsy D. PMID: 20102681.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Systemic lupus erythematosus clinical trials-an interim analysis. Nat Rev Rheumatol. 2009 Jun; 5(6):348-51. Dall'Era M, Wofsy D. PMID: 19491915.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis Rheum. 2007 Dec; 56(12):4142-50. Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D. PMID: 18050206.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCellsCTClinical Trials
    40. Six refractory lupus patients treated with rituximab: a case series. Arthritis Rheum. 2007 Apr 15; 57(3):538-42. Gillis JZ, Dall'era M, Gross A, Yazdany J, Davis J. PMID: 17394185.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. Clinical trial design in systemic lupus erythematosus. Curr Opin Rheumatol. 2006 Sep; 18(5):476-80. Dall'Era M, Wofsy D. PMID: 16896285.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Systemic lupus erythematosus. How to manage, when to refer. Postgrad Med. 2003 Nov; 114(5):31-7, 40. Dall'Era M, Davis JC. PMID: 14650091.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Maria's Networks
    Concepts (197)
    Derived automatically from this person's publications.
    _
    Co-Authors (26)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _